250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech VC Funds in Australia

A list of 50 VC funds that invest in Biotech startups based in Australia. We rank investors based on the number of investments they made in Biotech companies from Australia. We update this investor list every month.

Top 50 Biotech VC Funds in Australia

Investor Biotech Australia investments
Uniseed Ventures 21
Brandon Capital Partners 15
Medical Research Commercialisation Fund (MRCF) 11
Stoic VC 7
OneVentures 6
Melbourne Angels 5
Artesian VC 5
Starfish Ventures 3
Yuuwa Capital 3
Vectr 2
Horizons Ventures 2
South Australian Venture Capital Fund 2
Main Sequence Ventures 2
CEFC 2
Folklore Ventures 2
Sydney Angels 2
Grok Ventures 2
Global Health Investment Fund (GHIF) 2
Brisbane Angels 2
Lowercarbon Capital 2
BridgeLane Capital 2
Innovation Capital 1
AbbVie Biotech Ventures 1
Acequia Capital (AceCap) 1
Acre Venture Partners 1
Transition Level Investments 1
Nanyang Ventures 1
AustralianSuper 1
Regal Funds Management 1
Australian Nuclear Science and Technology Organization 1
Accelerating Commercialisation - AusIndustry 1
Hostplus 1
Terra Rossa Capital 1
Thistledown Capital 1
Square Peg Capital 1
Southern Cross Venture Partners 1
Plymouth Growth 1
Alta Partners 1
BioScience Managers Limited 1
Vaekstfonden 1
Negev Capital 1
Lionheart Ventures 1
Empath Ventures 1
Playford Capital 1
ATP Innovations 1
Ellerston Capital 1
Giant Leap Fund 1
Possible Ventures 1
Time Ventures 1
Alloy Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia · 4 investments in the past 12 months
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Science/Engineering, Health Care, Biotechnology
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
  • Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Brandon Capital Partners VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months
Brandon Capital Partners is a funds management business aiming to generate quality returns for Australia's leading superannuation funds by investing in innovative life science ventures. Our team works with entrepreneurs to build businesses, creating value for the entrepreneurs, their teams and our investors.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Entact Bio — Creating new medicines by enhancing protein function. We are scientists, entrepreneurs, drug creators, and problem solvers, working together to bring new medicines to patients who currently have few options.
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
Stoic VC VC Fund · Sydney, New South Wales, Australia
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
  • Science/Engineering, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Wildlife Drones — Wildlife Drones are leaders in animal tracking and wildlife conservation. Wildlife Drones offers innovative radio telemetry drone technology.
  • OccuRx — OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with venture funding from the Medical Research Commercialisation Fund, Brandon Capital Partners and Uniseed. The Company’s primary focus is on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis.
OneVentures VC Fund · Sydney, New South Wales, Australia · 5 investments in the past 12 months
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
  • Software, Health Care, Science/Engineering
  • Series A, Funding Round, Debt Financing
  • Australia, United States, United Kingdom
Portfolio highlights
  • XY Sense — XY Sense is the leading occupancy sensor platform helping workplace teams access and act on data in real-time. Supercharge your return to office with XY Sense.
  • HIVERY — HIVERY is an innovative AI Category Management Optimization company delivering AI solutions to CPGs and Retailers.
  • Helios — HELIOS is developing technologies to extract and utilize metals and oxygen from martian and lunar soil, providing fuel and construction materials for future space missions.
Melbourne Angels VC Fund · Melbourne, Victoria, Australia
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
  • Science/Engineering, Software, Commerce/Shopping
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Insite AI — Join Consumer Goods leaders who win in Category Management and Revenue Growth Management with the best Assortment & Trade Promotion Capabilities
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
  • Tayble — Spend more time enjoying your food and less time waiting.We hate waiting...For anything...And food and drinks are no exception!If your hobbies include:- Waiting in line - Calling out to a waiter - Watching the kettle boil - Calculating your split of the billPLEASE DO NOT DOWNLOAD THIS APP... YOU'LL HATE IT!But if you're likeus...And want your food and drinks ready exactly when you are...Or to leave a restaurant without worrying about your bill...Then step right up, this bad boy's for you!With Tayble, you’ll never have to flag down a waiter... EVER!Simply order from your "Tayble"Or before you even arrive...Leave the rest to us and the 1,000's of minions in the cloud that keep this all running!You’ll be left asking where has this been all my life, guaranteed!*(Definitely not a real guarantee)
Artesian VC VC Fund · Melbourne, Victoria, Australia · 27 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Science/Engineering, Data and Analytics
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Katonic.ai — Katonic MLOps Platform combines the creative scientific process of data scientists with the professional software engineering process to build and deploy Machine Learning Models into production safely, quickly, and in a sustainable way.
  • Altris.AI — AI for Ophthalmology & Optometry is the future of eye care. It will set high diagnostic standards for the industry and bring better patient outcome as a result. Together we will solve the preventable blindness problem.
Starfish Ventures VC Fund · Melbourne, Victoria, Australia
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
  • Software, Internet, Hardware
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines
Portfolio highlights
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,095,171 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani Health is developing a prenatal care platform which includes a wearable, textile-based product to measure key vital statistics of women and their developing fetus, for use during pregnancy, labor & delivery. The products utilize Artificial Intelligence to better assess health & wellness during pregnancy, labor & delivery. Maraniis collaborating with key partners including The Mayo Clinic.
  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
Yuuwa Capital VC Fund · Perth, Western Australia, Australia
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.
Show more
Investment focus
  • Software, Data and Analytics, Media and Entertainment
  • Seed, Series A, Series B
  • Australia
Portfolio highlights
  • Nexgen Plants Pty Limited — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld Pty Ltd — Agworld Farm Management software allows you to collect data at all levels and enables you to extract maximum value from this data; optimising profitability. The Agworld ecosystem is utilised by growers, agronomists and service providers on farms across the world.
Vectr VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 8 investments in the past 12 months
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
  • Software, Financial, Science/Engineering
  • Seed, Series A, Pre-Seed
  • United States, Hong Kong, Singapore
Portfolio highlights
  • Tellus — Our mobile app makes passive income accessible to everyone. Earn high yield outside the stock and crypto markets. Budget smarter, set goals, and save faster through your own actions in the app. Even manage your rental properties. Join now!
  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
  • Hello Clever — The first Australian buy-to-earn platform that makes shopping, payments, and money management easier for all. Trusted by 30,000+ Australians and 1,000+ merchants. Join us now!
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 22 investments in the past 12 months
Horizons Ventures focuses on investing in disruptive and technology-focused start-ups. The firm was founded in 1999 and is based in Hong Kong. Some of the latest exits are Skype, Siri, Facebook, Summly, and Waze.
Show more
Investment focus
  • Software, Science/Engineering, Data and Analytics
  • Series A, Series B, Seed
  • United States, United Kingdom, Israel
Portfolio highlights
  • Q-CTRL — Infrastructure software to power the quantum future
  • Asimov — Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.
  • Syzygy Plasmonics — Illuminating Chemical Engineering. Where everyday chemicals like hydrogen are made from light instead of heat - it's called photocatalysis.
South Australian Venture Capital Fund VC Fund · Adelaide, South Australia, Australia
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more
Investment focus
  • Health Care, Hardware, Software
  • Funding Round, Series B
  • Australia
Portfolio highlights
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Lumary — SaaS platform for NDIS and Aged Care service providers to manage their internal workflow and business process.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Main Sequence Ventures VC Fund · Sydney, New South Wales, Australia · 13 investments in the past 12 months
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
  • Science/Engineering, Software, IT
  • Series A, Seed, Series B
  • Australia, United States
Portfolio highlights
  • Advanced Navigation — Advanced Navigation provides industry-leading inertial navigation systems and robotics technologies for sea, land and air. Get in touch with us today.
  • ULUU — ULUU is an exciting new renewable biomaterial that's incredible for our oceans and climate. ULUU is made from renewable resource, farmed seaweed!
  • Samsara Eco — Samsara Eco is an enviro-tech company creating infinite recycling to end plastic pollution.
CEFC VC Fund · Sydney, New South Wales, Australia · 9 investments in the past 12 months
The Clean Energy Finance Corporation invests, applying commercial rigour, to increase the flow of finance into the clean energy sector. Their mission is to accelerate Australia's transformation towards a more competitive economy in a carbon constrained world, by acting as a catalyst to increase investment in emissions reduction. They do thisthrough an investment strategy focused on cleaner power solutions, including large and small-scale solar, wind and bioenergy; and a better built environment, with investments to drive more energy efficient property, vehicles, infrastructure and industry. The CEFC also invests with co-financiers to develop new sources of capital for the clean energy sector, including climate bonds, equity funds, aggregation facilities and other financial solutions. The CEFC operates under the Clean Energy Finance Corporation Act 2012.
Show more
Investment focus
  • Sustainability, Energy, Natural Resources
  • Series B, Series A, Seed
  • Australia, United States
Portfolio highlights
  • Relectrify — Unlocking extra lifetime and performance of batteries via advanced battery management (BMS) technology.
  • Samsara Eco — Samsara Eco is an enviro-tech company creating infinite recycling to end plastic pollution.
  • ACEN Australia — A clean energy company with a global track record
Folklore Ventures VC Fund · Sydney, New South Wales, Australia · 5 investments in the past 12 months
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
  • Software, Data and Analytics, IT
  • Seed, Series A, Funding Round
  • Australia, New Zealand, United States
Portfolio highlights
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • Swoop Aero — Transforming how the world moves by making access to the skies seamless.
  • Strong Compute — Strong Compute is building the future of Cloud Computing, priced by performance not consumption. Our software and hardware optimizations speed up neural network development 10x-1000x, file transfer 1000x, instance start time 10x. We're starting with AI and are aimed at the $500B cloud market.
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, Internet, Commerce/Shopping
  • Seed, Angel, Funding Round
  • Australia, United States
Portfolio highlights
  • Trendspek — From small assets to entire sites, Trendspek recreates reality to the millimetre and provides the tools and workflows to remotely inspect and plan; better than you could onsite.
  • Kapiche — Kapiche is a B2B SaaS company that has built an experience intelligence platform to help customer-centric organisations understand and optimize the experiences they deliver. The platform is built around their Natural Language Processing technology which can take 10s of 1,000s of pieces of unseen customer/employee feedback data (both structuredand unstructured) and, in minutes, with no prior setup and no pre-trained models, identify the salient themes being discussed, how the respondents feel about those themes, and what impact it has on your business.
  • Bandicoot Imaging Sciences — The easy, fast and affordable way to create high-quality digital 3D fabrics for fashion, furnishing and interior. Turn your physical fabrics into digital fabrics with just a camera!
Grok Ventures VC Fund · Surry Hills, New South Wales, Australia · 6 investments in the past 12 months
Grok Ventures is a private investment company. They back world-class teams solving big problems to shape a better future. They invest in fast growing technology-enabled businesses.
Show more
Investment focus
  • Software, Sustainability, Energy
  • Series A, Series B, Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • WeaveGrid — WeaveGrid operates with utilities and owners of electric vehicles (EV) to allow and speed up transportation electrification. Using machine learning, optimization, and predictive analytics, the company's software solution solves several EV-grid integration challenges for utilities in a systems-oriented manner; helps integrate renewable energyresources on the grid; and saves utility customers' money on their bills.
  • Vow — Vow is crafting a new category of food
  • Sundrive Solar — SunDrive Solar is a Wollongong based technology start-up creating lower cost, higher efficiency, more material abundant solar cells.
Global Health Investment Fund (GHIF) VC Fund · New York, New York, United States · 3 investments in the past 12 months
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series B, Series C, Funding Round
  • United States, India, Austria
Portfolio highlights
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Brisbane Angels VC Fund · Brisbane, Queensland, Australia
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more
Investment focus
  • Software, Science/Engineering, IT
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
  • Tribu — Here at tribu we aim to make running an MSP stress-free and simple. Remove complexity and repetitive shackles to give you the freedom in business so that you can have freedom in life.
  • Kapiche — Kapiche is a B2B SaaS company that has built an experience intelligence platform to help customer-centric organisations understand and optimize the experiences they deliver. The platform is built around their Natural Language Processing technology which can take 10s of 1,000s of pieces of unseen customer/employee feedback data (both structuredand unstructured) and, in minutes, with no prior setup and no pre-trained models, identify the salient themes being discussed, how the respondents feel about those themes, and what impact it has on your business.
Lowercarbon Capital VC Fund · New York, New York, United States · 30 investments in the past 12 months
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more
Investment focus
  • Science/Engineering, Sustainability, Energy
  • Series A, Seed, Series B
  • United States, United Kingdom, India
Portfolio highlights
  • Floodbase — Floodbase is an end-to-end flood data solution for designing and triggering global parametric flood coverage.
  • Sublime Systems — Sublime Systems develops technology to decarbonize cement.
  • Mill — So long, smelly bags. Goodbye, greenhouse gasses. Reserve your membership today and make a real difference from your kitchen.
BridgeLane Capital VC Fund · Sydney, New South Wales, Australia
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more
Investment focus
  • Hardware, Software, Data and Analytics
  • Seed
  • Australia
Portfolio highlights
  • Evrima Technologies — Evrima transforms the recruitment process for clinical trials to help clinicians accelerate timelines and increase patient awareness.
  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
Innovation Capital VC Fund · Sydney, New South Wales, Australia
An Australian venture capital firm building global technology businesses
Show more
Investment focus
  • Software, Music and Audio, Internet
  • Funding Round, Series A
  • Australia
Portfolio highlights
  • Weathertrends 360 — Weathertrends 360 is a global, web solution.
  • VPIsystems — VPIsystems (formerly VPI Virtual Photonics) develops and markets network planning software and services for the telecommunications industry in the United States and internationally. Its products include Photonic Design Automation, a solution for the modeling and optimization of photonic components and subsystems; and OnePlan, an integrated networkplanning system that enables communications service providers, systems integrators, and manufacturers to design, plan, and implement their transition to an IP-based network. The company serves wireline, wireless, and broadband carriers; and network equipment manufacturers and optical equipment vendors. VPIsystems, Inc. has strategic alliances with Accenture, HP, Logica, and Tech Mahindra. The company was founded as VPI Virtual Photonics, Inc. in 1997 and changed its name to VPIsystems, Inc. in July 2001. VPIsystems, Inc. is based in Holmdel, New Jersey with additional offices in Europe, Asia, and Australia.
  • Audinate — Introducing Dante AV-H for H.26x video productsDante AV-H brings interoperability to AV-over-IP products, providing easy-to-use discovery, connectivity and manageability while using the familiar, reliable H.264/265 codecs already supported in common hardware./products/manufacturer-products/dante-av-video?link=hm-r2-lc-dc Dante Domain ManagerSecurity, organization, scalability, and control for Dante networksNow available with subscription pricing for all editions to fit your budget and purchasing needs […]
AbbVie Biotech Ventures VC Fund · North Chicago, Illinois, United States
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more
Investment focus
  • Biotechnology, Science/Engineering, Health Care
  • Series A, Series B, Series C
  • United States, China, Italy
Portfolio highlights
  • AmbAgon Therapeutics — AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
  • Nitrase Therapeutics — Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is onParkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
  • Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
Acequia Capital (AceCap) VC Fund · Seattle, Washington, United States · 33 investments in the past 12 months
Acequia Capital advises early founders passionate about the power of software to grow broad, durable value. We assist founders developing their idea and forming the team through their journey. We provide seed capital, help to organize initial investors, secure bridge funding when appropriate, and lead or take part in rounds beyond Series A. Andwe can facilitate a market for founders, employees, and other investors via secondary sales. In select cases, we can provide alternative financing options.
Show more
Investment focus
  • Software, Science/Engineering, IT
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, France
Portfolio highlights
  • Supernormal — Supernormal AI automatically transcribes and writes the meeting notes for Google Meet. Save five to ten minutes every meeting. Instantly shareable to Google Drive, Notion, Quip, Slack, Hubspot, Salesforce and more.
  • IDBiologics — Solving infectious diseases
  • Tailor Bio — Tailor Bio develops an AI-driven drug discovery platform for pan-cancer medicine by decoding chromosomal instability. They respond to customer inquiries by email.
Acre Venture Partners VC Fund · Santa Monica, California, United States · 5 investments in the past 12 months
Driven by a mission to redefine food, Acre invests in companies creating systemic change in the food system to address the growing problems of human and environmental health. Acre makes venture-stage investments in highly disruptive platform business across the food value chain, with a particular focus on the agriculture, food tech and consumerverticals. Taken together, these investments have the ability to form the foundation of an integrated new approach to food system evolution.
Show more
Investment focus
  • Food/Beverage, Gaming, Science/Engineering
  • Series A, Series B, Series C
  • United States, Brazil, Argentina
Portfolio highlights
  • People Science — People Science offers data collection technology and services for clinical research studies of alternative medicines and wellness interventions.
  • Planet FWD — Planet FWD is the leading carbon assessment platform for consumer brands.
  • BCD Bioscience — BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States.
Transition Level Investments VC Fund · Brisbane, Queensland, Australia
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more
Investment focus
  • Software, Financial, IT
  • Seed, Pre-Seed, Series A
  • Australia, United States
Portfolio highlights
  • Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
  • Kapiche — Kapiche is a B2B SaaS company that has built an experience intelligence platform to help customer-centric organisations understand and optimize the experiences they deliver. The platform is built around their Natural Language Processing technology which can take 10s of 1,000s of pieces of unseen customer/employee feedback data (both structuredand unstructured) and, in minutes, with no prior setup and no pre-trained models, identify the salient themes being discussed, how the respondents feel about those themes, and what impact it has on your business.
  • FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
Nanyang Ventures VC Fund · Sydney, New South Wales, Australia
Nanyang Ventures invests with the aim of building listable companies. Company spokesman John Mulquiney said the Genetic Solutions management team had been successful at commercialising the company's technology.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series A
  • Australia
Portfolio highlights
  • QRxPharma — QRxPharma is an Australian-based, commercial-stage specialty pharmaceutical company focused on the development and commercialization of new pain management and abuse prevention productsBased on a development strategy that focuses on enhancing the clinical utility of currently approved compounds as well as bringing new products to market, thecompany's product portfolio includes both late and early stage clinical drug candidates with the potential for reduced risk, abbreviated development paths, and improved patient outcomes.In Q4 2013, the Company plans to refile with the US Food and Drug Administration a New Drug Application for its lead product candidate, immediate release MOXDUO®, for the treatment of acute pain. QRxPharma has entered into strategic agreements with Actavis Inc., Paladin Labs Inc. and Aspen Group for the commercialisation of immediate release MOXDUO in the US, Canada, Australia (including New Zealand and Oceania) and South Africa.The Company's clinical pipeline includes an intravenous (IV) and controlled release (CR) formulation of MOXDUO. QRxPharma is also collaborating with Aesica Formulation Development Limited, for the worldwide promotion of QRxPharma's proprietary Stealth Beadlets™ abuse deterrence technology.
AustralianSuper VC Fund · Melbourne, Victoria, Australia
AustralianSuper is run only to benefit members, offering low fees and strong long-term investment returns.
Show more
Investment focus
  • IT, Financial, Other
  • Funding Round, Series A, Series C
  • Australia, United States, United Kingdom
Portfolio highlights
  • Peel Ports — Peel Ports is a unique network of strategically situated ports, terminals, hubs, shipping lines, and state-of-the-art services.
  • SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
  • Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
Regal Funds Management VC Fund · Sydney, New South Wales, Australia · 4 investments in the past 12 months
Regal Funds Management aims to provide investors with absolute returns over the medium to long term, through a suite of investment products in both listed and unlisted equities. The Regal Emerging Companies Fund focuses on Pre-IPO, later stage VC, expansion capital and listed micro-cap opportunities.
Show more
Investment focus
  • Software, Financial, IT
  • Funding Round, Convertible Note, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • Shaype — Build unique financial experiences faster, smarter and with more confidence.
  • Platinum Asset Management — Platinum Asset Management is an Australian based fund manager which specialises in investing in international equities; it trades as Platinum Asset Management ("Platinum"​). Platinum's investment methodology is applied with the aim of achieving absolute returns for investors. This is our central endeavour. It is complemented byquarterly communication which attempts to keep Investors abreast of our perspective and portfolio positioning.
Australian Nuclear Science and Technology Organization VC Fund · Clayton, Victoria, Australia
Australian Nuclear Science and Technology Organisation is one of Australia's most important research infrastructures. Thousands of scientists in industry and academia gain access to state-of-the-art instruments every year. ANSTO operates much of Australia's landmark infrastructure, including OPAL, one of the world's most advancednuclear reactors; the Australian Synchrotron; the National Imaging Facility Research Cyclotron; and the Centre for Accelerator Science.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Funding Round
  • Australia
Portfolio highlights
  • Clarity Pharmaceuticals — Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
Accelerating Commercialisation - AusIndustry VC Fund · Canberra, Australian Capital Territory, Australia
A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda
Show more
Investment focus
  • Hardware, Software, Health Care
  • Grant
  • Australia
Portfolio highlights
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
  • Neuromersiv — Immersive, Engaging Brain Rehabilitation Therapy Using Virtual Reality.
Hostplus VC Fund · Melbourne, Victoria, Australia · 10 investments in the past 12 months
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more
Investment focus
  • Science/Engineering, Software, Sustainability
  • Series B, Series C, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • Oxbotica — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
  • Diffblue — Diffblue helps accelerate your shift left by automatically writing suites of unit regression tests so you can catch errors faster and earlier in your pipeline
  • Vow — Vow is crafting a new category of food
Terra Rossa Capital VC Fund · Adelaide, South Australia, Australia
Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series B
  • Australia
Portfolio highlights
  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Thistledown Capital VC Fund · Ottawa, Ontario, Canada
Thistledown Capital is a venture capital firm.
Show more
Investment focus
  • Science/Engineering, Energy, Hardware
  • Series A, Funding Round
  • Canada, Germany, Australia
Portfolio highlights
  • Marvel Fusion — Our mission is to enable humankind to access clean, safe & reliable energy by building a laser-driven fusion power plant.
  • Loam Bio — Loam Bio is developing tech that allows for crops to be inoculated with symbiotic micro-organisms.
  • General Fusion — General Fusion is developing fusion energy: a clean, safe, abundant and on-demand approach to generating electricity.
Square Peg Capital VC Fund · Melbourne, Victoria, Australia · 26 investments in the past 12 months
Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.
Show more
Investment focus
  • Software, Internet, IT
  • Series A, Series B, Seed
  • Australia, United States, Singapore
Portfolio highlights
  • Partly — Auto parts distributors, manufacturers, dismantlers, marketplaces and software providers use Partly's software and API to add fitment and manage parts online.
  • ROKT — Rokt is the global leader in ecommerce technology & software solutions, driving more value per transaction with personalized experiences. Request a demo today.
  • SaasGuru — Get started with a personalised cert prep journey and make your certification goal a reality in two weeks. Salesforce and ServiceNow Certifications
Southern Cross Venture Partners VC Fund · North Sydney, New South Wales, Australia
Southern Cross Venture Partners was launched in 2006 by veteran venture capitalists who have managed and operated companies themselves. Southern Cross Venture Partners assist early stage technology companies that demonstrate the potential for exceptional growth and market leadership build significant businesses. The founding principle of SouthernCross is partnership -- they are passionately committed to doing everything they can to help their portfolio companies succeed. Their team has a strong record of utilizing their start-up and management experience, industry knowledge, network of business/customer relationships, and recruiting skills to assist in building significant shareholder value.Southern Cross is currently investing in companies that fit their investment criteria. They prefer to act as lead or co-lead in the early stages where they have experience that can help build value rapidly. They do not have a minimum investment amount, however, a typical initial investment will be $2 million to $5 million with an ability to invest more money in later rounds.
Show more
Investment focus
  • Software, Energy, Science/Engineering
  • Funding Round, Series A, Series B
  • United States, Australia, Singapore
Portfolio highlights
  • Sunman — Sunman Energy is a technology company founded by a group of industry veterans delivering the future of Solar. Through the research and development of composite materials, Sunman has successfully commercialized the world’s first glass-free, lightweight and flexible Panel – eArc. Replacing glass completely, eArc brings solar power to markets andapplication scenarios that were previously impossible.
  • Wave Computing — The future of high-tech in online casino is a bright one. For example, RFID technology will help casinos track and identify stolen chips. In addition, these systems can also predict player behavior and betting patterns. The latter are especially useful if a player is caught while he is trying to switch out his cards. These ... Read more
  • Brisbane Materials Technology — Since 2005, we have helped thousands of people get the perfect domain name.
Plymouth Growth VC Fund · Ann Arbor, Michigan, United States · 2 investments in the past 12 months
Growth Capital for Leading Midwest Tech Companies
Show more
Investment focus
  • Software, IT, Hardware
  • Series A, Funding Round, Series B
  • United States, Canada, Australia
Portfolio highlights
  • Forj — Host your association's conferences, trade shows, or events on our highly customizable and interactive virtual event platform, backed by our customer success team.
  • CloseSimple — CloseSimple is a real estate based software firm making conversation around buying or selling a house easier through Text Message & Email.
  • Deck Commerce — Deck Commerce Order Management System (OMS) simplifies complex order processes to empower retailers to curate the best customer experience.
Alta Partners VC Fund · San Francisco, California, United States · 10 investments in the past 12 months
Alta Partners is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series B, Series A, Series C
  • United States, Spain, Canada
Portfolio highlights
  • BetterVet — At BetterVet.com, we believe pets deserve more than just a regular vet visit. We provide high quality mobile veterinary care. Book pet appointments online now!
  • Allakos — Allakos develops antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 immune response plays a key role in pathology, including allergic disease, inflammation, and diseases characterized by excess production of inflammatory cells. Its antibodies target cell types implicated in allergic and inflammatoryresponses. Allakos was founded in 2012 and is headquartered in San Carlos, California.
  • Novome Biotechnologies — Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The Company has developed the first-ever platform for controlled colonization of the gut with engineered bacteria, enabling first-in-class living therapeutics: Genetically Engineered MicrobialMedicines (GEMMs). Novome is utilizing its proprietary GEMMs platform in its lead preclinical program in hyperoxaluria, which is focused on the development of a therapeutic strain of bacteria that degrades oxalate to prevent the formation of kidney stones. Efforts are also directed to the expansion of its proprietary synthetic biology platform into additional indications.
BioScience Managers Limited VC Fund · Melbourne, Victoria, Australia
BioScience Managers Pty Ltd (formerly IB Managers) is a leading life sciences investment firm, headquartered in Melbourne, Australia. Established in 2003, BioScience Managers offers a global, multi-disciplinary team, bringing an international perspective together with the track record, networks and expertise required to convert that perspectiveinto informed, high return investment decisions.We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.
Show more
Investment focus
  • Health Care, Biotechnology, Community/Lifestyle
  • Funding Round
  • Canada, Australia
Portfolio highlights
  • Canary Medical — Canary is giving medical devices a voice and letting medical data be heard.
  • Nexvet — Our mission is to be a revolutionary force in the growing US$25 billion global animal pharmaceutical market. Only Nexvet can produce therapeutic antibodies that are 100% customised to target new species – like cats and dogs.Monoclonal antibody therapies have represented a new generation of highly effective, safe and targeted medicines inhumans. We think it’s time companion animals reaped the benefits of human medical progress in this field.Nexvet’s unique technology, PETisation™, ensures 100% customisation of a therapy to a new species, reducing the chances of immune challenges, and ensuring a more ‘natural’ fit between the therapy and the patient. Many chronic conditions in pets remain poorly treated by current veterinary therapies, such as pain and various inflammatory diseases– which has guided Nexvet’s focus towards these indications.To ensure we succeed in transforming animal medicine, we’ve brought together a team with an extraordinary global track record in animal and human health. We are working with leading contractors, advisors, drug development partners, academic groups, veterinarians and animal interest groups around the world to develop our pipeline to the highest standards.Senior executives and researchers from the world’s largest animal health brands are counted among our Board, management, and advisors, and together we’re building connections worldwide to make our vision a reality.
Vaekstfonden VC Fund · Hellerup, Hovedstaden, Denmark · 24 investments in the past 12 months
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
  • Software, Science/Engineering, IT
  • Seed, Funding Round, Pre-Seed
  • Denmark, United States, United Kingdom
Portfolio highlights
  • Orbex Space — Founded in 2015, Orbex is Europe’s leading private launch services company, focused entirely on supporting the needs of the small satellite industry.Orbex has developed one of the most advanced, low carbon, high performance micro-launch vehicles in the world. They launch customer satellites into polar and sun-synchronous low Earth orbits from aunique, modern launch location in the heart of the European continent.They offer a flexible core launch service and a wide suite of supporting services that make life easier for customers. Their European location means shorter supply lines, easier communications and reduced operational costs. Their advanced launch vehicle means higher reliability, more flexible mission profiles and a regular, scheduled launch service.
  • Go Autonomous — B2B commerce, simplified. Fastest way for companies to digitize manual quotes and orders. An order-to-cash automation SaaS platform powered by AI
  • Captego — Unique, high-speed field data capture. Empower your inspectors & surveyors with our unique collection app. Benefit from high quality data to automate reports and data insights.
Negev Capital VC Fund · Grand Cayman, Midland, Cayman Islands · 2 investments in the past 12 months
Psychedelic Medical Intervention Investment Fund
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Seed, Series A, Series B
  • United States, Canada, United Kingdom
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Mindstate Design Labs — A psychedelic drug development company designing altered states of consciousness for mental health therapeutics.
  • Delix Therapeutics — Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics.
Lionheart Ventures VC Fund · San Francisco, California, United States · 5 investments in the past 12 months
Lionheart Ventures is a global, seed-stage venture capital firm investing in companies that make humanity more resilient. Our focus areas are climate protection, mental health and financial inclusion.
Show more
Investment focus
  • Science/Engineering, Software, IT
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Singapore
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
  • Trek Health — Trek Health builds foundational software that empowers mental health providers to start working with insurance networks. The company's contact modes are by mail, phone, and physical address.
Empath Ventures VC Fund · Los Angeles, California, United States · 2 investments in the past 12 months
Empath Ventures is a venture capital firm that mainly invests in psychedelic medicine companies. The firm specializes in the fields of investment financial services, finance, and venture capital. It was founded in 2021 and headquartered in Los Angeles California.
Show more
Investment focus
  • Biotechnology, Science/Engineering
  • Seed
  • Australia
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Kanna Health — Kanna Health is a preclinical stage biopharma company developing novel therapeutics from kanna alkaloids to alleviate patient suffering and unmet medical needs.
Playford Capital VC Fund · Adelaide, South Australia, Australia
Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series B
  • Australia
Portfolio highlights
  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
ATP Innovations VC Fund
ATP Innovations accelerates the growth of technology companies that target global markets, by providing advice and guidance from seasoned entrepreneurs, access to investors, customers and domain specialists, and world-class infrastructure tailored to the needs of startup companies. The ATP Innovations Accelerator HUB is home to Startmate, IgnitionLabs and university accelerator programs. ATP Innovations’ portfolio comprises over 65 companies from the software, hardware and life science sectors.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Funding Round
  • Australia
Portfolio highlights
  • Clarity Pharmaceuticals — Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
Ellerston Capital VC Fund · Sydney, New South Wales, Australia · 5 investments in the past 12 months
Ellerston Capital is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.
Show more
Investment focus
  • Software, IT, Other
  • Funding Round, Seed, Series A
  • Australia, Hong Kong, United Kingdom
Portfolio highlights
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Internet 2.0 — Internet 2.0 specializes in cyber security, intelligence, cloud, cyber defense, Encryption, ransomware, malware, and cyber consulting.
  • Willed — Willed is an Australian online estate planning platform.
Giant Leap Fund VC Fund · Melbourne, Victoria, Australia · 6 investments in the past 12 months
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
  • Software, Health Care, Sustainability
  • Seed, Series A, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Fortanix — Fortanix is building a new security category with its Runtime Encryption(R) technology using Intel SGX. Just like encryption today protects data at rest and data during motion, Runtime Encryption(R) keeps keys, data, and applications completely protected even when infrastructure has been compromised and even root users are malicious.Fortanix's Self-Defending Key Management Service (SDKMS) is a next-generation cloud native solution for your enterprise encryption needs. It offers key generation, management, distribution, encryption-as-a-service, HSM, KMIP, and tokenization all rolled-in as a single product the highest possible level of security and cloud scale. Available as both FIPS certified appliance and a globally available SaaS (with Equinix's strong SLA), SDKMS offers incredible simple central management, server-side load balancing, central tamper-proof logging, RESTful APIs, and Runtime Encryption(R) plugin to run custom code.Fortanix's Runtime Encryption(R) Platform allows customers to bring any docker container and run them securely inside Intel SGX without any modification. It allows customers to share data with each other without losing control of the data, run analytics on sensitive data, run applications securely in remote cloud, move PII-heavy sensitive data to public cloud, etc. Fortanix's Enclave Development Platform (EDP) allows customers to write Rust code to run natively as SGX enclaves. Supported by mainline Rust compiler, developers find EDP as the easiest and the most secure way of developing new applications.In the short time, Fortanix has developed strategic partnership with Equinix and IBM cloud and counts multiple F50 companies as its customers. Fortanix is a Gartner Cool Vendor and also was runner up in RSA Innovation Sandbox among 500+ security companies where judges called it "holy grail of security". Fortanix has more than ten patents pending for its innovation.
  • Great Wrap — The only Australian made and owned compostable cling wrap
  • Swoop Aero — Transforming how the world moves by making access to the skies seamless.
Possible Ventures VC Fund · 26 investments in the past 12 months
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
  • Software, Science/Engineering, Hardware
  • Seed, Pre-Seed, Series A
  • Germany, United Kingdom, Australia
Portfolio highlights
  • ULUU — ULUU is an exciting new renewable biomaterial that's incredible for our oceans and climate. ULUU is made from renewable resource, farmed seaweed!
  • Return Protocol — Stake your crypto for perpetual climate impact. Show the world with a dynamic Soulbound Token.
  • Februar — Februar provides payment infrastructure for Web3 and digital payments.
Time Ventures VC Fund · 13 investments in the past 12 months
Time Ventures is an investment fund for Marc Benioff.
Show more
Investment focus
  • Software, Science/Engineering, Data and Analytics
  • Series A, Series B, Seed
  • United States, Canada, Colombia
Portfolio highlights
  • Dryad Networks — Overview of Dryad, providing ultra-early fire detection as well as forest growth and health monitoring.
  • you.com — You.com is an ad-free, private search engine that you control. Customize search results with 150 apps alongside web results. Access a zero-trace private mode.
  • Regrow Ag — At Regrow, we empower farmers and partners to transform agriculture, build regenerative practices and combat climate change.
Alloy Ventures
Alloy Ventures is an early stage venture capital firm that invests in the areas of life sciences, information technology, and cleantech.
Show more
Investment focus
  • Health Care, Science/Engineering, Software
  • Series C, Series B, Series D
Investors by industry
Investors by country
VC Funds in Australia by industry